Combinatorial biosynthesis of plant-specific coumarins in bacteria

Metabolic Engineering

Volumn 18, Issue , 2013, Pages 69-77

  Lin, Yuheng ^a   Sun, Xinxiao ^b   Yuan, Qipeng ^b   Yan, Yajun ^a  

^a University of Georgia   (United States)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Combinatorial biosynthesis; Coumarin; Plant metabolites; Scopoletin; Umbelliferone

Indexed keywords

COMBINATORIAL BIOSYNTHESIS; COUMARIN; PLANT METABOLITES; SCOPOLETIN; UMBELLIFERONE;

BACTERIA; BIOSYNTHESIS; ESCHERICHIA COLI; MOLECULES;

BIOCHEMISTRY;

FERULIC ACID; PARA COUMARIC ACID; SCOPOLETIN; UMBELLIFERONE;

ARTICLE; BACTERIUM CULTURE; BIOSYNTHESIS; BIOTRANSFORMATION; CELL GROWTH; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; ENZYME ASSAY; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

COUMARINS; ESCHERICHIA COLI; METABOLIC ENGINEERING; PLANTS;

ESCHERICHIA COLI;

EID: 84878364563     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2013.04.004     Document Type: Article

References (59)

1. Ajikumar P.K., Xiao W.H., Tyo K.E., Wang Y., Simeon F., Leonard E., Mucha O., Phon T.H., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
2. Bachmann B.O. Biosynthesis: is it time to go retro?. Nat. Chem. Biol. 2010, 6:390-393.
3. Balunas M..J., Kinghorn A..D. Drug discovery from medicinal plants. Life Sci. 2005, 78:431-441.
4. Bourgaud F., Hehn A., Larbat R., Doerper S., Gontier E., Kellner S., Matern U. Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochem. Rev. 2006, 5:293-308.
5. Butler M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67:2141-2153.
6. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 2008, 25:475-516.
7. Chemler J.A., Koffas M.A. Metabolic engineering for plant natural product biosynthesis in microbes. Curr. Opin. Biotechnol. 2008, 19:597-605.
8. Chin Y.W., Balunas M.J., Chai H.B., Kinghorn A.D. Drug discovery from natural sources. Aaps J. 2006, 8:E239-E253.
9. Colling J., Groenewald J.H., Makunga N.P. Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae). Metab. Eng. 2010, 12:561-572.
10. Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. J. Nat. Prod. 1997, 60:52-60.
11. Ehlting J., Buttner D., Wang Q., Douglas C.J., Somssich I.E., Kombrink E. Three 4-coumarate:coenzyme A ligases in Arabidopsis thaliana represent two evolutionarily divergent classes in angiosperms. Plant J. 1999, 19:9-20.
12. Farmer W.R., Liao J.C. Improving lycopene production in Escherichia coli by engineering metabolic control. Nat. Biotechnol. 2000, 18:533-537.
13. Fullbeck M., Michalsky E., Dunkel M., Preissner R. Natural products: sources and databases. Nat. Prod. Rep. 2006, 23:347-356.
14. Gestetner B., Conn E.E. The 2-hydroxylation of trans-cinnamic acid by chloroplasts from Melilotus alba Desr. Arch. Biochem. Biophys. 1974, 163:617-624.
15. Gibson D.G., Young L., Chuang R.Y., Venter J.C., Hutchison C.A., Smith H.O. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods. 2009, 6:343-345.
16. Harvey R.G., Cortez C., Ananthanarayan T.P., Schmolka S. A new coumarin synthesis and its utilization for the synthesis of polycyclic coumarin compounds with anticarcinogenic properties. J. Org. Chem. 1988, 53:3936-3943.
17. Haskins F.A., Williams L.G., Gorz H.J. Light-induced trans to cis conversion of beta-d-glucosyl o-hydroxycinnamic acid in Melilotus alba leaves. Plant Physiol. 1964, 39:777-781.
18. Hawkins K.M., Smolke C.D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat. Chem. Biol. 2008, 4:564-573.
19. Huang Q., Roessner C.A., Croteau R., Scott A.I. Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg. Med. Chem. 2001, 9:2237-2242.
20. Hunter D.J., Behrendorff J.B., Johnston W.A., Hayes P.Y., Huang W., Bonn B., Hayes M.A., De Voss J.J., Gillam E.M. Facile production of minor metabolites for drug development using a CYP3A shuffled library. Metab. Eng. 2011, 13:682-693.
21. Kai K., Mizutani M., Kawamura N., Yamamoto R., Tamai M., Yamaguchi H., Sakata K., Shimizu B. Scopoletin is biosynthesized via ortho-hydroxylation of feruloyl CoA by a 2-oxoglutarate-dependent dioxygenase in Arabidopsis thaliana. Plant J. 2008, 55:989-999.
22. Khosla C., Keasling J.D. Metabolic engineering for drug discovery and development. Nat. Rev. Drug Discov. 2003, 2:1019-1025.
23. Kleinhofs A., Haskins F.A., Gorz H.J. Trans-o-hydroxycinnamic acid glucosylation in cell-free extracts of Melilotus alba. Phytochemistry 1967, 6:1313-1318.
24. Kontogiorgis C.A., Savvoglou K., Hadjipavlou-Litina D.J. Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J. Enzyme Inhib. Med. Chem. 2006, 21:21-29.
25. Kostova I., Raleva S., Genova P., Argirova R. Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors. Bioinorg. Chem. Appl. 2006, 68274.
26. Lacy A., O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr. Pharm. Des. 2004, 10:3797-3811.
27. Leonard E., Lim K.H., Saw P.N., Koffas M.A. Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli. Appl. Environ. Microbiol. 2007, 73:3877-3886.
28. Lim C.G., Fowler Z.L., Hueller T., Schaffer S., Koffas M.A. High-yield resveratrol production in engineered Escherichia coli. Appl. Environ. Microbiol. 2011, 77:3451-3460.
29. Lin Y., Yan Y. Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex. Microb. Cell. Fact. 2012, 11:42.
30. Lutz R., Bujard H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 1997, 25:1203-1210.
31. Marshall M.E., Butler K., Fried A. Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies. Mol. Biol. Ther. 1991, 3:170-178.
32. Matsumoto S., Mizutani M., Sakata K., Shimizu B. Molecular cloning and functional analysis of the ortho-hydroxylases of p-coumaroyl coenzyme A/feruloyl coenzyme A involved in formation of umbelliferone and scopoletin in sweet potato, Ipomoea batatas (L.) Lam. Phytochemistry 2012, 74:49-57.
33. McChesney J.D., Venkataraman S.K., Henri J.T. Plant natural products: back to the future or into extinction?. Phytochemistry 2007, 68:2015-2022.
34. Minami H., Kim J.S., Ikezawa N., Takemura T., Katayama T., Kumagai H., Sato F. Microbial production of plant benzylisoquinoline alkaloids. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7393-7398.
35. Mitchell W. Natural products from synthetic biology. Curr. Opin. Chem. Biol. 2011, 15:505-515.
36. Mohler J.L., Gomella L.G., Crawford E.D., Glode L.M., Zippe C.D., Fair W.R., Marshall M.E. Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate 1992, 20:123-131.
37. Musa M.A., Cooperwood J.S., Khan M.O. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr. Med. Chem. 2008, 15:2664-2679.
38. Nakagawa A., Minami H., Kim J.S., Koyanagi T., Katayama T., Sato F., Kumagai H. A bacterial platform for fermentative production of plant alkaloids. Nat. Commun. 2011, 2:326.
39. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70:461-477.
40. Newman D.J., Cragg G.M., Snader K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17:215-234.
41. Newman D.J., Cragg G.M., Snader K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66:1022-1037.
42. Oba K., Conn E.E., Canut H., Boudet A.M. Subcellular localization of 2-(beta-d-glucosyloxy)-cinnamic acids and the related beta-glucosidase in leaves of Melilotus alba Desr. Plant Physiol. 1981, 68:1359-1363.
43. Paterson I., Anderson E.A. The renaissance of natural products as drug candidates. Science 2005, 310:451-453.
44. Poulton J.E., McRee D.E., Conn E.E. Intracellular localization of two enzymes involved in coumarin biosynthesis in Melilotus alba. Plant Physiol. 1980, 65:171-175.
45. Redding-Johanson A.M., Batth T.S., Chan R., Krupa R., Szmidt H.L., Adams P.D., Keasling J.D., Lee T.S., Mukhopadhyay A., Petzold C.J. Targeted proteomics for metabolic pathway optimization: application to terpene production. Metab. Eng. 2011, 13:194-203.
46. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., Chang M.C., Withers S.T., Shiba Y., Sarpong R., Keasling J.D. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
47. Santos C.N., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab. Eng. 2011, 13:392-400.
48. Shen C.R., Liao J.C. Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways. Metab. Eng. 2008, 10:312-320.
49. Stanchev S., Momekov G., Jensen F., Manolov I. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives. Eur. J. Med. Chem. 2008, 43:694-706.
50. Stoker J.R., Bellis D.M. The biosynthesis of coumarin in Melilotus alba. J. Biol. Chem. 1962, 237:2303-2305.
51. Thornes R.D., Daly L., Lynch G., Breslin B., Browne H., Browne H.Y., Corrigan T., Daly P., Edwards G., Gaffney E. Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J. Cancer Res. Clin. Oncol. 1994, 120:S32-S34. (Suppl.).
52. Vannelli T., Wei Qi W., Sweigard J., Gatenby A.A., Sariaslani F.S. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metab. Eng. 2007, 9:142-151.
53. Vialart G., Hehn A., Olry A., Ito K., Krieger C., Larbat R., Paris C., Shimizu B., Sugimoto Y., Mizutani M., Bourgaud F. A 2-oxoglutarate-dependent dioxygenase from Ruta graveolens L. exhibits p-coumaroyl CoA 2'-hydroxylase activity (C2'H): a missing step in the synthesis of umbelliferone in plants. Plant J. 2012, 70:460-470.
54. Yan Y., Chemler J., Huang L., Martens S., Koffas M.A. Metabolic engineering of anthocyanin biosynthesis in Escherichia coli. Appl. Environ. Microbiol. 2005, 71:3617-3623.
55. Yan Y., Kohli A., Koffas M.A. Biosynthesis of natural flavanones in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2005, 71:5610-5613.
56. Yan Y., Huang L., Koffas M.A. Biosynthesis of 5-deoxyflavanones in microorganisms. Biotechnol. J. 2007, 2:1250-1262.
57. Yan Y., Li Z., Koffas M.A. High-yield anthocyanin biosynthesis in engineered Escherichia coli. Biotechnol. Bioeng. 2008, 100:126-140.
58. Yoon S.H., Lee E.G., Das A., Lee S.H., Li C., Ryu H.K., Choi M.S., Seo W.T., Kim S.W. Enhanced vanillin production from recombinant E. coli using NTG mutagenesis and adsorbent resin. Biotechnol. Prog. 2007, 23:1143-1148.
59. Zhou H., Xie X., Tang Y. Engineering natural products using combinatorial biosynthesis and biocatalysis. Curr. Opin. Biotechnol. 2008, 19:590-596.